BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND B2M, P61769, 567, ENSG00000166710 AND Prognosis
20 results:

  • 1. Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303.
    Russler-Germain DA; Krysiak K; Ramirez C; Mosior M; Watkins MP; Gomez F; Skidmore ZL; Trani L; Gao F; Geyer S; Cashen AF; Mehta-Shah N; Kahl BS; Bartlett NL; Alderuccio JP; Lossos IS; Ondrejka SL; Hsi ED; Martin P; Leonard JP; Griffith M; Griffith OL; Fehniger TA
    Blood Adv; 2023 Sep; 7(18):5524-5539. PubMed ID: 37493986
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Addition of Hypomethylating Agents to Low-Intensity Induction Chemotherapy Does Not Improve Outcomes in Elderly Acute Myeloid leukemia Patients: A Single-Center Retrospective Study.
    Liu D; Wang X; Tong J; Zhou L; Chen E; Zhou Z; Xue L; Zhang X; Sun G; Zheng C
    Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676738
    [No Abstract]    [Full Text] [Related]  

  • 3. A novel immune-related epigenetic signature based on the transcriptome for predicting the prognosis and therapeutic response of patients with diffuse large B-cell lymphoma.
    Wang X; Hong Y; Meng S; Gong W; Ren T; Zhang T; Liu X; Li L; Qiu L; Qian Z; Zhou S; Zhao M; Zhai Q; Meng B; Ren X; Zhang H; Wang X
    Clin Immunol; 2022 Oct; 243():109105. PubMed ID: 36055572
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. High occurrence of CRLF2 abnormalities in Mexican children with B-cell acute lymphoblastic leukemia.
    Juárez-Velázquez MDR; Moreno-Lorenzana DL; Martínez Anaya DA; Hernández Monterde EA; Aguilar-Hernández MM; Reyes-León A; Chávez-González MA; López Santiago N; Zapata Tarrés M; Juárez Villegas L; Rivera Sánchez N; Soto Lerma O; Vega-Vega L; Rivera Luna R; Pérez-Vera P
    Cytokine; 2022 Jul; 155():155896. PubMed ID: 35537330
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A novel clinical immune-related prognostic model predicts the overall survival of mantle cell lymphoma.
    Lv H; Fei Y; Li W; Wang Y; Wang J; He J; Liu X; Li L; Qiu L; Qian Z; Zhou S; Meng B; Zhai Q; Ren X; Zou D; Cai Q; Wang X; Zhang H
    Hematol Oncol; 2022 Aug; 40(3):343-355. PubMed ID: 35368100
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Tracking the evolution of untreated high-intermediate/high-risk diffuse large B-cell lymphoma by circulating tumour DNA.
    Zhang S; Zhang T; Liu H; Zhao J; Zhou H; Su X; Liu X; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; He J; Wang X; Zhang H
    Br J Haematol; 2022 Feb; 196(3):617-628. PubMed ID: 34664256
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Allogeneic hematopoietic stem cell transplantation for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 B-cell precursor acute lymphoblastic leukemia in first complete remission: impact of pretransplant measurable residual disease (MRD) status. An analysis from the Acute leukemia Working Party of the EBMT.
    Esteve J; Giebel S; Labopin M; Czerw T; Wu D; Volin L; Socié G; Yakoub-Agha I; Maertens J; Cornelissen JJ; Pigneux A; Shimoni A; Schwerdtfeger R; Labussière-Wallet H; Russell N; Schattenberg A; Chevallier P; Koza V; Foà R; Schmid C; Peric Z; Mohty M; Nagler A
    Leukemia; 2021 Aug; 35(8):2232-2242. PubMed ID: 33542481
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Interaction network of proteins associated with unfavorable prognosis in acute myeloid leukemia.
    Rendon-Rodriguez JJ; Restrepo-Rodriguez LF; Rothlisberger S
    Acta Biochim Pol; 2020 Dec; 67(4):475-483. PubMed ID: 33284559
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [E-cadherin Expression in Children with Acute leukemia and Its Clinical Significance].
    Bao BX; An XZ; Li PF; Li YJ; Cui YH; Tang X; Liu QH; Hu YN; Liu W; Liang SY; Yu J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):339-347. PubMed ID: 30998135
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [The expression and prognostic significance of microRNA-34a in Uygur and Han patients with chronic lymphocytic leukemia in Xinjiang Uygur Autonomous Region in China].
    Liu H; Wang XM; Mao M; Fu L; Huang Q; Wang YL; Wang YC; Wang ZS; Li Y
    Zhonghua Nei Ke Za Zhi; 2018 Dec; 57(12):922-925. PubMed ID: 30486562
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation.
    Qin YZ; Wang Y; Zhu HH; Gale RP; Zhang MJ; Jiang Q; Jiang H; Xu LP; Chen H; Zhang XH; Liu YR; Lai YY; Jiang B; Liu KY; Huang XJ
    Chin J Cancer; 2016 May; 35():46. PubMed ID: 27197573
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patients.
    Van Damme M; Crompot E; Meuleman N; Mineur P; Dessars B; El Housni H; Bron D; Lagneaux L; Stamatopoulos B
    Epigenetics; 2014 Oct; 9(10):1374-81. PubMed ID: 25437053
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Serum immunoglobulin levels at diagnosis have no prognostic significance in stage A chronic lymphocytic leukemia: a study of 1113 cases from the Israeli CLL Study Group.
    Shvidel L; Tadmor T; Braester A; Bairey O; Rahimi-Levene N; Herishanu Y; Klepfish A; Ruchlemer R; Berrebi A; Polliack A;
    Eur J Haematol; 2014 Jul; 93(1):29-33. PubMed ID: 24547751
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia.
    Del Poeta G; Del Principe MI; Maurillo L; Rossi FM; Buccisano F; Ammatuna E; Simotti C; Zucchetto A; Catalano G; Bulian P; Bruno A; Venditti A; De Fabritiis P; Gattei V; Amadori S
    Leuk Lymphoma; 2010 Jan; 51(1):95-106. PubMed ID: 20001236
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Expression of soluble CD27 and interleukins-8 and -10 in B-cell chronic lymphocytic leukemia: correlation with disease stage and prognosis.
    Kara IO; Sahin B; Gunesacar R
    Adv Ther; 2007; 24(1):29-40. PubMed ID: 17526459
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The effect of total-ABL, GUS and b2m control genes on BCR-ABL monitoring by real-time RT-PCR.
    Rulcová J; Zmeková V; Zemanová Z; Klamová H; Moravcová J
    Leuk Res; 2007 Apr; 31(4):483-91. PubMed ID: 16945414
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
    Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
    Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants.
    Tricot G; Sawyer JR; Jagannath S; Desikan KR; Siegel D; Naucke S; Mattox S; Bracy D; Munshi N; Barlogie B
    J Clin Oncol; 1997 Jul; 15(7):2659-66. PubMed ID: 9215838
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities.
    Tricot G; Barlogie B; Jagannath S; Bracy D; Mattox S; Vesole DH; Naucke S; Sawyer JR
    Blood; 1995 Dec; 86(11):4250-6. PubMed ID: 7492784
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Plasma cell myeloma--new biological insights and advances in therapy.
    Barlogie B; Epstein J; Selvanayagam P; Alexanian R
    Blood; 1989 Mar; 73(4):865-79. PubMed ID: 2465790
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.